Article Details
Retrieved on: 2022-01-25 20:03:28
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
FDA limits use of two monoclonal antibodies as Omicron dominates U.S. case count. — Pfizer and BioNTech have begun testing an Omicron-specific ...
Article found on: www.politico.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here